Valuation: Cutia Therapeutics

Market Cap 756M 876M 112M 98.08M 91.21M 83.7M 157M 10.75B 160M 1.08B 423M 5.29B 419M 410M 18.28B P/E 2026 *
-4.54x
P/E 2027 * 16x
Enterprise Value 825M 955M 122M 107M 99.5M 91.3M 172M 11.73B 174M 1.18B 462M 5.77B 457M 447M 19.94B EV / Sales 2026 *
1.28x
EV / Sales 2027 * 0.64x
Free-Float
35.23%
Yield 2026 *
-
Yield 2027 * -
1 day-1.66%
1 week-3.66%
Current month-16.25%
1 month-15.05%
3 months-49.68%
6 months-46.38%
Current year-47.80%
1 week 2.14
Extreme 2.14
2.67
1 month 2.14
Extreme 2.14
2.88
Current year 2.14
Extreme 2.14
5.51
1 year 2.14
Extreme 2.14
12
3 years 2.14
Extreme 2.14
31
5 years 2.14
Extreme 2.14
32.6
10 years 2.14
Extreme 2.14
32.6
Manager TitleAgeSince
Chief Executive Officer 48 2019-08-31
Director of Finance/CFO 36 2021-05-09
Chief Tech/Sci/R&D Officer 42 2020-01-09
Director TitleAgeSince
Chairman 63 2019-08-22
Director/Board Member 48 2023-06-11
Director/Board Member 57 2025-12-29
Date Insider Type Main position Quantity % Market Cap.
10/15/24 Other

Founder

15,000 0.0049%
10/3/24 Other

Chief Financial Officer

20,000 0.0066%
10/2/24 Other

Chief Financial Officer

30,000 0.0098%
Change 5-day change 1-year change 3-year change Capi.($)
-1.66%-3.66%-75.21%-88.44% 112M
+0.86%+1.43%+47.17%+163.68% 1,067B
+1.59%+4.09%+56.51%+52.50% 635B
+0.95%+1.91%+36.30%+82.78% 458B
+1.60%+6.25%+37.00%+31.03% 347B
-0.60%+1.52%+36.67%+41.41% 295B
-0.14%+0.60%+17.29%+18.74% 262B
+0.09%-2.82%-29.09%-39.57% 216B
+1.22%+2.66%+22.66%+59.87% 203B
-1.18%-3.70%+11.28%+67.52% 161B
Average +0.27%+1.11%+16.06%+38.95% 364.36B
Weighted average by Cap. +0.76%+1.95%+35.99%+79.09%

Financials

2026 *2027 *
Net sales 646M 748M 95.39M 83.78M 77.91M 71.49M 134M 9.19B 136M 925M 361M 4.52B 358M 350M 15.61B 1.18B 1.37B 174M 153M 142M 131M 245M 16.78B 249M 1.69B 660M 8.25B 654M 640M 28.52B
Net income -146M -169M -21.52M -18.9M -17.58M -16.13M -30.31M -2.07B -30.78M -209M -81.56M -1.02B -80.8M -79.06M -3.52B 44.25M 51.25M 6.53M 5.74M 5.34M 4.9M 9.2M 629M 9.34M 63.38M 24.76M 309M 24.53M 24M 1.07B
Net Debt 68.7M 79.57M 10.15M 8.91M 8.29M 7.6M 14.29M 977M 14.51M 98.41M 38.45M 480M 38.09M 37.27M 1.66B -
Logo Cutia Therapeutics
Cutia Therapeutics is an investment holding company principally engaged in the dermatology biopharmaceutical business. The Company is dedicated to developing solutions in the dermatology treatment and care market, including scalp diseases and care, skin diseases and care, topical anesthesia and localized adipose accumulation management. The Company is primarily engaged in the distribution of scalp diseases and care products, as well as certain skin care products. The Company's principal pipeline products include topical finasteride spray CU-40102, topical 4% minocycline foam CU-10201, topical novel small molecule agent CU-10101, localized topical lidocaine and tetracaine cream CU-30101 and recombinant mutant collagenase CU-20401.
Employees
304
Date Price Change Volume
26-07-27 HK$2.370 -1.66% 105,200
26-07-24 HK$2.410 -6.23% 232,400
26-07-23 HK$2.570 +0.78% 32,400
26-07-22 HK$2.550 -2.30% 131,000
26-07-21 HK$2.610 +6.10% 110,600
Trader
Investor
-
Global
-
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
2.081CNY
Average target price
9.801CNY
Spread / Average Target
+371.02%

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 2487 Stock